IRIS
BOLIGNANO, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.015
EU - Europa 2.018
AS - Asia 1.474
SA - Sud America 545
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.963
SG - Singapore 640
SE - Svezia 540
BR - Brasile 493
IE - Irlanda 490
CN - Cina 439
RU - Federazione Russa 238
DE - Germania 210
HK - Hong Kong 191
UA - Ucraina 123
FI - Finlandia 108
GB - Regno Unito 80
IT - Italia 77
FR - Francia 65
VN - Vietnam 65
IN - India 41
CA - Canada 24
AR - Argentina 23
PL - Polonia 18
BD - Bangladesh 16
MX - Messico 16
CZ - Repubblica Ceca 14
JP - Giappone 13
ZA - Sudafrica 13
ES - Italia 12
TR - Turchia 12
BE - Belgio 11
AT - Austria 9
IQ - Iraq 9
EC - Ecuador 8
MA - Marocco 8
ID - Indonesia 7
VE - Venezuela 7
LV - Lettonia 6
AE - Emirati Arabi Uniti 5
TN - Tunisia 5
AZ - Azerbaigian 4
CO - Colombia 4
UZ - Uzbekistan 4
AL - Albania 3
CH - Svizzera 3
CI - Costa d'Avorio 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GY - Guiana 3
NI - Nicaragua 3
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
EG - Egitto 2
HN - Honduras 2
IR - Iran 2
KE - Kenya 2
NL - Olanda 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
GT - Guatemala 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
PA - Panama 1
RO - Romania 1
TG - Togo 1
TW - Taiwan 1
Totale 7.091
Salva come PNG Salva come JPEG
Città #
Chandler 499
Dublin 490
Ashburn 384
Dallas 324
Singapore 319
Jacksonville 282
Nyköping 251
Beijing 213
Hong Kong 191
Dearborn 90
Los Angeles 84
The Dalles 84
Princeton 73
Cambridge 69
Medford 64
Munich 63
New York 59
Des Moines 56
Moscow 52
Ann Arbor 50
Boardman 50
Buffalo 32
São Paulo 30
Helsinki 27
Ho Chi Minh City 27
Bremen 25
Lancaster 22
San Mateo 20
Tianjin 19
Woodbridge 19
Jinan 18
Frankfurt am Main 17
Hanoi 16
Wilmington 16
Belo Horizonte 15
Redondo Beach 15
Seattle 15
Turku 15
Pune 13
Warsaw 13
Nanjing 12
Santa Clara 12
Tokyo 12
Brooklyn 11
Brussels 11
Düsseldorf 11
Houston 11
Brasília 10
Chennai 10
Porto Alegre 10
Shenyang 10
Atlanta 9
Curitiba 9
Denver 9
Haikou 9
Hebei 9
Johannesburg 9
Montreal 9
Ningbo 9
Augusta 8
Boston 8
Brno 8
Chicago 8
Rio de Janeiro 8
Stockholm 8
Dhaka 7
Falls Church 7
Hyderabad 7
Nanchang 7
Tappahannock 7
Bexley 6
Guangzhou 6
Lauterbourg 6
Leawood 6
London 6
Mexico City 6
Orem 6
Riga 6
Washington 6
Campinas 5
Carapicuíba 5
Charlotte 5
Jiaxing 5
Manaus 5
Norwalk 5
Olomouc 5
Portsmouth 5
Recife 5
San Francisco 5
Toronto 5
Zhengzhou 5
Baku 4
Blumenau 4
Buenos Aires 4
Campos dos Goytacazes 4
Columbus 4
Contagem 4
Goiânia 4
Guarulhos 4
Hangzhou 4
Totale 4.546
Salva come PNG Salva come JPEG
Nome #
Both IL-1β and TNF-α Regulate NGALExpression in Polymorphonuclear Granulocytes ofChronic Hemodialysis Patients 161
A brief "update" on renal effects of caffeine 153
Dialysis and the Elderly: An Underestimated Problem. 144
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 143
Caffeine and the kidney: What evidence right now? 132
[Erythropoietin: pleiotropic actions]. 129
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 128
A new therapy for kidney injury: regeneration. 124
Cold pressor test stimulates the mobilization of endothelial progenitor cells in hypertensive and uremic patients 123
Acute cardiovascular complications of hemodialysis. 123
Down with the erythropoietin. Long live the erythropoietin! 123
The erythropoietin and regenerative medicine: a lesson from fish 122
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. 122
Effects of haemodialysis on circulating endothelial progenitor cell count 121
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 120
Aquaretic agents: What's beyond the treatment of hyponatremia? 119
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 119
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 117
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life. 116
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. 113
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 109
Aquaretic-induced apoptosis: a cure or a curse? 109
Therapy with vasopressin receptor antagonists: the aquaretics 109
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 108
Neurobiological model and quality of life in discovering personality of the uremic patient. 107
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 107
Renal complications in oncohematologic patients. 107
Neutrophilgelatinase-associatedlipocalin(NGAL); un biomarker oltre i confini della nefrologia 107
Malnutrition in the elderly patient on dialysis. 104
Erythropoietin and its lost receptor [8] 104
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 103
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 102
Pregnancy in uremic patients: An eventful journey 101
Erythropoietin and its lost receptor. 100
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 99
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 99
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 98
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 97
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide. 97
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 95
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 93
Erythropoietin and cancer: an old risk. 92
Regenerative medicine: does Erythropoietin have a role? 92
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 91
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 90
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 90
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 90
Experimental therapies in renal replacement: The effect of two different potassium acetate-free biofiltration protocols on striated muscle fibers 90
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 88
Il Cold Pressor Test stimola la mobilizzazione di cellule staminali ad indirizzo endoteliale nei soggetti ipertesi ed uremici 88
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 87
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 84
Genomic damage in endothelial progenitor cells from uremic patients. 82
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 80
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 80
Pulmonary hypertension and erythropoietin. 77
NGAL is a precocious marker of therapeutic response. 77
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 77
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 73
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 73
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 73
Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. 69
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 68
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 64
Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: An observational retrospective cohort study 64
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 62
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 61
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 57
NGAL: a new missing link between inflammation and uremic anemia? 54
Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir 50
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement? 48
null 39
Neutrophil gelatinase-associated lipocalin levels in patients with crohn disease undergoing treatment with infliximab. 37
null 30
Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. 28
null 16
Totale 7.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021223 0 0 0 0 0 60 6 24 7 39 57 30
2021/2022544 2 73 5 19 32 4 26 17 3 120 76 167
2022/20231.563 134 169 75 144 124 152 9 94 609 7 31 15
2023/2024326 31 50 14 32 27 98 2 21 0 14 5 32
2024/20251.543 24 14 53 99 43 62 35 296 393 120 150 254
2025/20261.909 277 334 345 265 388 300 0 0 0 0 0 0
Totale 7.128